Is CAR-T therapy right for you?
A haematology team in India checks from your reports whether CAR-T cell therapy could suit you, and explains the steps and the cost before you travel.
- Eligibility checked by haematologists before you travel
- Approved in India for certain relapsed or refractory B-cell blood cancers
- Stay, monitoring and follow-up planned in advance
10,000+ patients supported15+ years in medical travel4.9/5 Google rating
A clear roadmap before you begin. No ambiguity.
Four steps, and you know what happens at each one before it happens.
Share your reports (WhatsApp works)
Diagnosis, recent scans and every treatment so far.
Eligibility review
A haematology team checks whether CAR-T could suit you.
Plan and one quote
Cell collection, infusion, monitoring and stay, with the full cost.
Therapy and follow-up
Close monitoring in India, then follow-up at home.
Why choose us?
Haematology teams experienced with CAR-T
Partner centres that collect, infuse and monitor CAR-T patients.
A straight answer on eligibility
Whether CAR-T suits you, or which other option fits better.
The whole stay planned
CAR-T needs weeks near the hospital. We plan travel, stay and visas around it.
One coordinator
From your first message to follow-up after you return home.
What CAR-T care includes
Not sure which of these applies to you? Send your reports and the specialists will tell you.
Book consultation- Eligibility review of reports
- B-cell lymphoma
- B-cell acute lymphoblastic leukaemia
- Cell collection (apheresis)
- Bridging therapy if needed
- CAR-T infusion
- Hospital monitoring
- Stay near the hospital
- Follow-up at home
- Second opinion on other options
Hospitals we coordinate with
Questions families ask
Who can have CAR-T cell therapy in India?
CAR-T therapies made in India are approved by the national regulator, CDSCO, for certain B-cell blood cancers that have come back or not responded to earlier treatment, such as some B-cell lymphomas and B-cell acute lymphoblastic leukaemia. Whether it suits you depends on your diagnosis, past treatment and current health, and only the treating haematologist can decide that.
Which reports should I send?
Your diagnosis report (biopsy or bone marrow), recent PET-CT or other scans, recent blood tests, and a list of every treatment you have had with dates. Clear phone photos are enough to start.
What about myeloma or other blood cancers?
CAR-T is not approved in India for every blood cancer. Send your reports and the team will tell you plainly whether any CAR-T option, or a different treatment, suits your case.
How long will I need to stay in India?
Usually several weeks. Cells are collected, the CAR-T cells are prepared, and after the infusion you are monitored closely, first in hospital and then staying near it. Your plan gives an estimate for your case.
How much does CAR-T cost in India?
The cost depends on the product, the hospital and how long you need to stay, so we quote only after the eligibility review. The written quote lists each part, and nothing is booked until you agree.
Can a family member come with me?
Yes, and for CAR-T a caregiver should stay with you throughout. India issues medical attendant visas for up to two family members, and we include them in the visa help.
Find out whether CAR-T cell therapy could suit you
Tell us how to reach you. We will ask for your reports on the call or on WhatsApp.
- Haematology team reviews your reports
- A written plan and one quote
- Visa, travel and stay arranged